Our findings provide a comprehensive picture of how Sox2 expression is regulated in CRC through acetylation, deacetylation, and O-GlcNAcylation modulated by ACSS2/p300, miR29a/HDAC4, and their interactive effects. The gene discussed is EP300; the disease is colorectal carcinoma.